TITLE

Rx Makers to Help Close Doughnut Hole

PUB. DATE
October 2010
SOURCE
Chain Drug Review;10/25/2010, Vol. 32 Issue 18, p84
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports on the move of the nation's pharmaceutical manufacturers to provide 50% discounts on the cost of covered branded prescription drugs to donees in the Medicare Part D coverage gap or doughnut hole.
ACCESSION #
55696924

 

Related Articles

  • U.S. Operates Top Drug Ring In The Nation. DEVON M. HERRICK // Investors Business Daily;10/30/2014, pA13 

    Medicare has a drug problem.

  • CMS rule would streamline prior authorizations for e-prescribing. Goedert, Joseph // Healthdatamanagement.com;6/17/2019, pN.PAG 

    Known as the Support for Patients and Communities Act, the rule would improve patients' access to medications by updating the prior authorization process for the Medicare Part D drug coverage program, which provides coverage for prescription drugs that beneficiaries pick up at the pharmacy counter.

  • Cost Sharing and Decreased Branded Oral Anti-Diabetic Medication Adherence Among Elderly Part D Medicare Beneficiaries. Sacks, Naomi; Burgess, James; Cabral, Howard; Pizer, Steven; McDonnell, Marie // JGIM: Journal of General Internal Medicine;Jul2013, Vol. 28 Issue 7, p876 

    BACKGROUND: Although the Medicare Part D coverage gap phase-out should reduce cost-related nonadherence (CRN) among seniors with diabetes, preferential generic prescribing may have already decreased CRN, while smaller numbers of patients using more costly branded oral anti-diabetic (OAD)...

  • Medicare Part D update: What to know for 2010. Egervary, Alex // Pharmacy Today;Nov2009, Vol. 15 Issue 11, p45 

    The article provides updates on the 2010 Medicare Part D that U.S. pharmacists need to know. It notes on the changes in the monthly premiums offered by the Medicare Advantage and the Medicare prescription drug plan (PDP), as well as on the medication therapy management (MTM) plans. It also...

  • Balancing Horizontal and Vertical Equity within Managed Health Plans Drug Benefit. Fincham, Jack E. // American Health & Drug Benefits;Sep/Oct2009, Vol. 2 Issue 6, p250 

    In this article, the author discusses a study on the effects of prescription benefit coverage limitations on medication adherence in managed care drug programs in the U.S. It notes that the study preceded the Medicare Part D program implementation which provides a capped benefit with the...

  • Medicare Part D: Increased drug coverage lowers other medical costs. Egerváry, Alex // Pharmacy Today;Oct2011, Vol. 17 Issue 10, p76 

    The article focuses on the effect of Medicare Part D to the medical costs covered by Medicare Part A and B. It mentions the report of J. Michael McWilliams and colleagues in the July 27, 2011 issue of "Journal of American Medical Association" which shows that Part D results to increase use of...

  • Meaningful use stage 2 e-prescribing threshold and adverse drug events in the Medicare Part D population with diabetes. Powers, Christopher; Gabriel, Meghan Hufstader; Encinosa, William; Mostashari, Farzad; Bynum, Julie // Journal of the American Medical Informatics Association;Sep2015, Vol. 22 Issue 5, p1094 

    Evidence supports the potential for e-prescribing to reduce the incidence of adverse drug events (ADEs) in hospital-based studies, but studies in the ambulatory setting have not used occurrence of ADE as their outcome. Using the "prescription origin code" in 2011 Medicare Part D prescription...

  • Concerns about Rx access raised.  // Chain Drug Review;10/27/2014, Vol. 36 Issue 17, p30 

    The article reports on the passage of legislation by pharmacist organization National Community Pharmacists Association regarding the Medicare Part D prescription drug benefit plans in the U.S. in 2014.

  • Comparison Friction: Experimental Evidence from Medicare Drug Plans *. Kling, Jeffrey R.; Mullainathan, Sendhil; Shafir, Eldar; Vermeulen, Lee C.; Wrobel, Marian V. // Quarterly Journal of Economics;Jan2012, Vol. 127 Issue 1, p199 

    Consumers need information to compare alternatives for markets to function efficiently. Recognizing this, public policies often pair competition with easy access to comparative information. The implicit assumption is that comparison friction—the wedge between the availability of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics